{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:25:40Z","timestamp":1790256340588,"version":"4.1.0"},"reference-count":47,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:sec>\n                  <jats:title>CONTEXT:<\/jats:title>\n                  <jats:p>Half of children experience wheezing by age 6 years, and optimal strategies for preventing severe exacerbations are not well defined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE:<\/jats:title>\n                  <jats:p>Synthesize the evidence of the effects of daily inhaled corticosteroids (ICS), intermittent ICS, and montelukast in preventing severe exacerbations among preschool children with recurrent wheeze.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DATA SOURCES:<\/jats:title>\n                  <jats:p>Medline (1946, 2\/25\/15), Embase (1947, 2\/25\/15), CENTRAL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY SELECTION:<\/jats:title>\n                  <jats:p>Studies were included based on design (randomized controlled trials), population (children \u22646 years with asthma or recurrent wheeze), intervention and comparison (daily ICS vs placebo, intermittent ICS vs placebo, daily ICS vs intermittent ICS, ICS vs montelukast), and outcome (exacerbations necessitating systemic steroids).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DATA EXTRACTION:<\/jats:title>\n                  <jats:p>Completed by 2 independent reviewers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Twenty-two studies (N = 4550) were included. Fifteen studies (N = 3278) compared daily ICS with placebo and showed reduced exacerbations with daily medium-dose ICS (risk ratio [RR] 0.70; 95% confidence interval [CI], 0.61\u20130.79; NNT = 9). Subgroup analysis of children with persistent asthma showed reduced exacerbations with daily ICS compared with placebo (8 studies, N = 2505; RR 0.56; 95% CI, 0.46\u20130.70; NNT = 11) and daily ICS compared with montelukast (1 study, N = 202; RR 0.59; 95% CI, 0.38\u20130.92). Subgroup analysis of children with intermittent asthma or viral-triggered wheezing showed reduced exacerbations with preemptive high-dose intermittent ICS compared with placebo (5 studies, N = 422; RR 0.65; 95% CI, 0.51\u20130.81; NNT = 6).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS:<\/jats:title>\n                  <jats:p>More studies are needed that directly compare these strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>There is strong evidence to support daily ICS for preventing exacerbations in preschool children with recurrent wheeze, specifically in children with persistent asthma. For preschool children with intermittent asthma or viral-triggered wheezing, there is strong evidence to support intermittent ICS for preventing exacerbations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2015-4496","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T12:14:17Z","timestamp":1464264857000},"source":"Crossref","is-referenced-by-count":114,"title":["Preventing Exacerbations in Preschoolers With Recurrent Wheeze: A Meta-analysis"],"prefix":"10.1542","volume":"137","author":[{"given":"Sunitha V.","family":"Kaiser","sequence":"first","affiliation":[{"name":"Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tram","family":"Huynh","sequence":"additional","affiliation":[{"name":"School of Public Health, University of California, Berkeley, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Bacharier","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, Davis, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh Anne","family":"Bakel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado, Denver, Colorado; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Parkin","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Cabana","sequence":"additional","affiliation":[{"name":"Department of Pediatrics,"},{"name":"Phillip Lee Institute for Health Policy Studies, and"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"issue":"3","key":"2021120904530545200_B1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM199501193320301","article-title":"Asthma and wheezing in the first six years of life.","volume":"332","author":"Martinez","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120904530545200_B2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1081-1206(10)61499-8","article-title":"Association between asthma control in children and loss of workdays by caregivers.","volume":"93","author":"Laforest","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021120904530545200_B3","author":"American Lung Association","year":"2014"},{"key":"2021120904530545200_B4","first-page":"2001","volume-title":"National surveillance of asthma","author":"Centers for Disease Control and Prevention","year":"2012"},{"issue":"5","key":"2021120904530545200_B5","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma\u2014summary report 2007.","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2021120904530545200_B6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-2867","article-title":"Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis.","volume":"123","author":"Castro-Rodriguez","year":"2009","journal-title":"Pediatrics"},{"issue":"19","key":"2021120904530545200_B7","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa051378","article-title":"Long-term inhaled corticosteroids in preschool children at high risk for asthma.","volume":"354","author":"Guilbert","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120904530545200_B8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00002108","article-title":"Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach.","volume":"32","author":"Brand","year":"2008","journal-title":"Eur Respir J"},{"issue":"3","key":"2021120904530545200_B9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaci.2006.12.607","article-title":"Severe intermittent wheezing in preschool children: a distinct phenotype.","volume":"119","author":"Bacharier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021120904530545200_B10","first-page":"878","article-title":"Phenotypic expressions of childhood wheezing and asthma: implications for therapy","volume-title":"J Pediatr","author":"Chipps","year":"2011"},{"key":"2021120904530545200_B11","author":"Global Initiative for Asthma"},{"issue":"5","key":"2021120904530545200_B12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/0009922807312184","article-title":"Periodic use of inhaled steroids in children with mild persistent asthma: what are pediatricians recommending?","volume":"47","author":"Sawicki","year":"2008","journal-title":"Clin Pediatr (Phila)"},{"issue":"9928","key":"2021120904530545200_B13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(14)60615-2","article-title":"Diagnosis, management, and prognosis of preschool wheeze.","volume":"383","author":"Ducharme","year":"2014","journal-title":"Lancet"},{"key":"2021120904530545200_B14","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2021120904530545200_B15","first-page":"1127","article-title":"Childhood asthma hospitalizations in the United States, 2000\u20132009","volume-title":"J Pediatr","author":"Hasegawa","year":"2013"},{"issue":"2","key":"2021120904530545200_B16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/adc.2009.171272","article-title":"The use of inhaled corticosteroids in the wheezy under 5-year-old child.","volume":"96","author":"Davies","year":"2011","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"4","key":"2021120904530545200_B17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2500\/aap.2015.36.3850","article-title":"Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: Systematic review and meta-analysis.","volume":"36","author":"Gionfriddo","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"2021120904530545200_B18","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane Statistical Methods Group. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"2021120904530545200_B19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jaci.2008.09.029","article-title":"Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.","volume":"122","author":"Bacharier","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2021120904530545200_B20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1164\/ajrccm.160.1.9811024","article-title":"The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study.","volume":"160","author":"Bisgaard","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2021120904530545200_B21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.rmed.2011.07.017","article-title":"Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy.","volume":"105","author":"Brand","year":"2011","journal-title":"Respir Med"},{"issue":"11","key":"2021120904530545200_B22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.rmed.2005.04.008","article-title":"The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms.","volume":"99","author":"Carlsen","year":"2005","journal-title":"Respir Med"},{"issue":"1","key":"2021120904530545200_B23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/adc.68.1.85","article-title":"Prevention of viral induced asthma attacks using inhaled budesonide.","volume":"68","author":"Connett","year":"1993","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021120904530545200_B24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/adc.69.3.351","article-title":"Use of budesonide in severe asthmatics aged 1-3 years.","volume":"69","author":"Connett","year":"1993","journal-title":"Arch Dis Child"},{"issue":"5","key":"2021120904530545200_B25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<310::AID-PPUL6>3.0.CO;2-Q","article-title":"Nebulized flunisolide in infants and young children with asthma: a pilot study.","volume":"21","author":"de Benedictis","year":"1996","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"2021120904530545200_B26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0091-6749(96)70221-X","article-title":"Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study.","volume":"98","author":"de Blic","year":"1996","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2021120904530545200_B27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0808907","article-title":"Preemptive use of high-dose fluticasone for virus-induced wheezing in young children.","volume":"360","author":"Ducharme","year":"2009","journal-title":"N Engl J Med"},{"issue":"6642","key":"2021120904530545200_B28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bmj.297.6642.163","article-title":"Controlled trial of budesonide given by the nebuhaler in preschool children with asthma.","volume":"297","author":"Gleeson","year":"1988","journal-title":"BMJ"},{"issue":"9537","key":"2021120904530545200_B29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(06)69285-4","article-title":"Secondary prevention of asthma by the use of Inhaled Fluticasone Propionate in Wheezy Infants (IFWIN): double-blind, randomised, controlled study.","volume":"368","author":"Murray","year":"2006","journal-title":"Lancet"},{"issue":"10","key":"2021120904530545200_B30","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1398-9995.2009.02134.x","article-title":"Regular vs prn nebulized treatment in wheeze preschool children.","volume":"64","author":"Papi","year":"2009","journal-title":"Allergy"},{"issue":"5","key":"2021120904530545200_B31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2006.07.045","article-title":"Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study.","volume":"149","author":"Qaqundah","year":"2006","journal-title":"J Pediatr"},{"issue":"4","key":"2021120904530545200_B32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1067\/mai.2001.118789","article-title":"Response of preschool children with asthma symptoms to fluticasone propionate.","volume":"108","author":"Roorda","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2021120904530545200_B33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1651-2227.1999.tb01266.x","article-title":"Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers.","volume":"88","author":"Svedmyr","year":"1999","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021120904530545200_B34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaip.2012.08.005","article-title":"Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.","volume":"1","author":"Szefler","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"2021120904530545200_B35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1081-1206(10)61343-9","article-title":"Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.","volume":"96","author":"Wasserman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"2021120904530545200_B36","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/adc.61.11.1108","article-title":"Nebulised beclomethasone dipropionate suspension.","volume":"61","author":"Webb","year":"1986","journal-title":"Arch Dis Child"},{"issue":"4","key":"2021120904530545200_B37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/adc.72.4.317","article-title":"Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children.","volume":"72","author":"Wilson","year":"1995","journal-title":"Arch Dis Child"},{"issue":"4","key":"2021120904530545200_B38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/adc.65.4.407","article-title":"Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home.","volume":"65","author":"Wilson","year":"1990","journal-title":"Arch Dis Child"},{"issue":"21","key":"2021120904530545200_B39","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1056\/NEJMoa1104647","article-title":"Daily or intermittent budesonide in preschool children with recurrent wheezing.","volume":"365","author":"Zeiger","year":"2011","journal-title":"N Engl J Med"},{"issue":"4 pt 1","key":"2021120904530545200_B40","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/ajrccm.162.4.9912111","article-title":"A clinical index to define risk of asthma in young children with recurrent wheezing.","volume":"162","author":"Castro-Rodr\u00edguez","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120904530545200_B41","first-page":"956","article-title":"Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone","volume-title":"J Allergy Clin Immunol","author":"Guilbert","year":"2011"},{"key":"2021120904530545200_B42","first-page":"CD009878","article-title":"Inhaled corticosteroids in children with persistent asthma: dose\u2013response effects on growth.","volume":"7","author":"Pruteanu","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120904530545200_B43","first-page":"CD008202","article-title":"Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.","volume":"10","author":"Brodlie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120904530545200_B44","first-page":"CD011032","article-title":"Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.","volume":"7","author":"Chong","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120904530545200_B45","first-page":"CD009611","article-title":"Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.","volume":"2","author":"Chauhan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120904530545200_B46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40733-016-0020-z","article-title":"Treatment of asthma in young children: evidence-based recommendations.","volume":"2","author":"Castro-Rodriguez","year":"2016","journal-title":"Asthma Res Pract."},{"key":"2021120904530545200_B47","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12660","article-title":"Stability and predictiveness of multiple trigger and episodic viral wheeze in preschoolers.","author":"van Wonderen","year":"2015","journal-title":"Clin Exp Allergy"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-4496\/1094996\/peds_20154496.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-4496\/1094996\/peds_20154496.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T21:51:43Z","timestamp":1639086703000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/137\/6\/e20154496\/52447\/Preventing-Exacerbations-in-Preschoolers-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,1]]},"published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-4496","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]},"article-number":"e20154496"}}